<!DOCTYPE html><html lang="en"><head><meta charset="utf-8"><meta name="viewport" content="width=device-width, initial-scale=1, minimum-scale=1, shrink-to-fit=no"><meta http-equiv="x-ua-compatible" content="ie=edge"><title>More Cancer Mutations, Better Immunotherapy Outcomes | The Scientist Magazine®</title><meta name="description" content="Immune checkpoint inhibitors are generally most effective against tumors with more genetic mutations, according to a new study, although the relationship isn't true for all cancers."><link rel="icon shortcut" href="/favicon.ico" type="image/x-icon"><link rel="icon" href="/favicon.png" type="image/x-icon"><link rel="stylesheet" href="https://cdn.the-scientist.com/static/4.51.0/css/the-scientist-website.css"><link rel="stylesheet" href="https://cdn.the-scientist.com/static/4.51.0/fonts/fonts.css"><link rel="canonical" href="https://www.the-scientist.com/news-opinion/more-cancer-mutations--better-immunotherapy-outcomes-65323"><script src="https://www.googletagservices.com/tag/js/gpt.js" async></script><meta property="og:title" content="More Cancer Mutations, Better Immunotherapy Outcomes"><meta property="og:description" content="Immune checkpoint inhibitors are generally most effective against tumors with more genetic mutations, according to a new study, although the relationship isn't true for all cancers."><meta property="og:image" content="https://cdn.the-scientist.com/assets/articleNo/65323/aImg/30255/infusion-m.png"><meta property="og:site_name" content="The Scientist Magazine®"><meta property="og:url"><meta name="twitter:card" content="summary_large_image"><meta name="twitter:title" content="More Cancer Mutations, Better Immunotherapy Outcomes"><meta name="twitter:description" content="Immune checkpoint inhibitors are generally most effective against tumors with more genetic mutations, according to a new study, although the relationship isn't true for all cancers."><meta name="twitter:image" content="https://cdn.the-scientist.com/assets/articleNo/65323/aImg/30255/infusion-l.png"><script type="application/ld+json">{
    "@context": "http://schema.org",
    "@type": "NewsMediaOrganization",
    "name": "The Scientist Magazine",
    "alternateName": "The Scientist",
    "url": "https://www.the-scientist.com/",
    "logo": "https://www.the-scientist.com/assets/logo_plain.svg"
}</script><link rel="amphtml" href="/news-opinion/more-cancer-mutations--better-immunotherapy-outcomes-65323/amp"><script type="application/ld+json">{
    "@context": "http://schema.org/",
    "@type": "NewsArticle",
    "headline": "More Cancer Mutations, Better Immunotherapy Outcomes",
    "datePublished": "Jan 15, 2019",
    "dateModified": "2019-01-15 20:10:26",
    "isFamilyFriendly":true,
    "description": "Immune checkpoint inhibitors are generally most effective against tumors with more genetic mutations, according to a new study, although the relationship isn&rsquo;t true for all cancers.",
    "inLanguage": "English",
    "mainEntityOfPage": "https://www.the-scientist.com/news-opinion/more-cancer-mutations--better-immunotherapy-outcomes-65323",
    "articleBody": "ABOVE: &copy; ISTOCK.COM, SUDOK1The number of mutations in a tumor&rsquo;s genome may predict how well a patient will benefit from treatment with immune checkpoint inhibitors, drugs that take the brakes off the immune system, according to a largescale study published yesterday (January 14) in Nature Genetics. Although previous research has already indicated that higher tumor mutational burden (TMB) is tied to better treatment outcomes, the current work, which includes data from more than 1,600 patients across multiple cancer types, provides some of the strongest and most detailed evidence for the link yet.Checkpoint inhibitor drugs work by blocking protein receptors that regulate the activity of T cells and other immune system components, thus boosting these cells&rsquo; antitumor activity. Bristol-Myers Squibb&rsquo;s nivolumab (Opdivo) and Merck&rsquo;s pembrolizumab (Keytruda) have made progress in clinical trials of late, with the latter therapy receiving regulatory approval from the US Food and Drug Administration in 2018.See &ldquo;Immunotherapy Drug Shows Promise for Melanoma, Lung Cancer&rdquo;Variation in patients&rsquo; responses to these drugs has led researchers to search for ways to predict who will benefit from which intervention. &ldquo;Given the potential toxicities of immunotherapy and the highly variable response to [immune checkpoint inhibitors], as well as the significant economic cost of these agents, there is an urgent need for biomarkers that can predict immunotherapy response,&rdquo; the researchers write in their paper.&nbsp;In the current study, a team of scientists led by Luc Morris of Memorial Sloan Kettering Cancer Center in New York City analyzed clinical information and DNA sequence data from 1,662 patients with advanced cancer who had been treated with checkpoint inhibitors. They found that, in general, people with a higher TMB responded better to the drugs than those with a lower mutational burden, although the relationship varied substantially across tumors. In glioma, for example, patients with a higher TMB didn&rsquo;t show any advantage over those with a lower TMB.See &ldquo;The Cancer Genes Needed for Immunotherapy Response&rdquo;It&rsquo;s not yet clear why more tumor mutations are linked with improved treatment outcomes. One popular theory is that a higher TMB makes a tumor cell appear more different from a normal cell by creating an abundance of abnormal proteins, which the immune system then recognizes and reads as a signal to destroy the tumor.Whatever the explanation, Morris notes that using TMB as a biomarker could help clinicians predict the outcome of checkpoint inhibitor therapies. &ldquo;Only in lung cancer is TMB being used in a clinical trial,&rdquo; he tells Forbes. &ldquo;Hopefully this data will give us permission to include it in future clinical trials on other cancer types.&rdquo;However, he adds that TMB is just &ldquo;one biomarker for response, but a number of other factors are important. I would not suggest you take the data from this paper and apply it to a patient in the clinic.&rdquo;See &ldquo;Opinion: Learning from Immunotherapy&rsquo;s Recent Failures&rdquo;",
    "keywords": "checkpoint inhibitor, immune checkpoint, immune checkpoint blocker, immunotherapy, cancer immunotherapy, cancer, disease & medicine, pharma & biotech, prediction, therapy, clinical research, genetics & genomics",
    "wordcount": "3180",
    "genre": "science",
    "image" : {
                                "@type": "ImageObject",
                                "height": "220",
                                "width": "220",
                                "url": "https://cdn.the-scientist.com/assets/articleNo/65323/aImg/30255/infusion-t.png"
                            },
    "author":[{ "@type": "Person",  "name": "Catherine Offord" }],
    "publisher": {
        "@type": "NewsMediaOrganization",
        "logo": {
            "@type": "ImageObject",
            "url": "https://www.the-scientist.com/assets/ts_wordmark60.png"
        },
        "name": "The Scientist Magazine"
    }
} </script><script id="GA">(function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){(i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)})(window,document,'script','//www.google-analytics.com/analytics.js','ga');
ga('create', 'UA-1151369-1', 'the-scientist.com');
ga('set', 'dimension1', 'Catherine-Offord');
ga('set', 'dimension2', 'News-Opinion');
ga('set', 'dimension3', 'checkpoint-inhibitor immune-checkpoint immune-checkpoint-blocker immunotherapy cancer-immunotherapy cancer disease-medicine pharma-biotech prediction therapy clinical-research genetics-genomics');
ga('set', 'dimension4', 'January 15, 2019');
ga('set', 'dimension5', '');
ga('send', 'pageview', '/news-opinion/more-cancer-mutations--better-immunotherapy-outcomes-65323');</script><script>dataLayer = [{"author":"Catherine Offord","category":"News-Opinion","allCategories":"News & Opinion","tags":"checkpoint inhibitor, immune checkpoint, immune checkpoint blocker, immunotherapy, cancer immunotherapy, cancer, disease & medicine, pharma & biotech, prediction, therapy, clinical research, genetics & genomics","publishDate":"January 15, 2019","pageType":"Article","contentType":"Online Only","contentSource":"Self Published","publishDate2":"01-15-2019","level":3,"mainCategory":"News & Opinion"}];</script><script id="GTM">(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start': new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-NGL8ZT6');</script></head><body class="preload"><noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-NGL8ZT6" height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript><header id="MainHeader"><div id="MainHeaderContent"><div class="main-container flex-justify-between flex-align-center"><a id="brand" href="/"></a><div id="MenusMobile" data-menus="[{&quot;menuNo&quot;:1,&quot;parentMenuNo&quot;:0,&quot;label&quot;:&quot;Main Navigation&quot;,&quot;url&quot;:&quot;/&quot;,&quot;orderNo&quot;:1,&quot;children&quot;:[{&quot;menuNo&quot;:76,&quot;parentMenuNo&quot;:1,&quot;label&quot;:&quot;News &amp; Opinion&quot;,&quot;url&quot;:&quot;/news-opinion&quot;,&quot;orderNo&quot;:0},{&quot;menuNo&quot;:77,&quot;parentMenuNo&quot;:1,&quot;label&quot;:&quot;Magazine&quot;,&quot;url&quot;:&quot;/magazine/current-issue&quot;,&quot;orderNo&quot;:1,&quot;children&quot;:[{&quot;menuNo&quot;:131,&quot;parentMenuNo&quot;:77,&quot;label&quot;:&quot;Current Issue&quot;,&quot;url&quot;:&quot;/magazine/current-issue&quot;,&quot;orderNo&quot;:0},{&quot;menuNo&quot;:132,&quot;parentMenuNo&quot;:77,&quot;label&quot;:&quot;Archives&quot;,&quot;url&quot;:&quot;/magazine&quot;,&quot;orderNo&quot;:1},{&quot;menuNo&quot;:134,&quot;parentMenuNo&quot;:77,&quot;label&quot;:&quot;Features&quot;,&quot;url&quot;:&quot;/features&quot;,&quot;orderNo&quot;:2},{&quot;menuNo&quot;:135,&quot;parentMenuNo&quot;:77,&quot;label&quot;:&quot;Infographics&quot;,&quot;url&quot;:&quot;/infographics&quot;,&quot;orderNo&quot;:3},{&quot;menuNo&quot;:136,&quot;parentMenuNo&quot;:77,&quot;label&quot;:&quot;Top 10 Innovations&quot;,&quot;url&quot;:&quot;/page/top-10-innovations&quot;,&quot;orderNo&quot;:4}]},{&quot;menuNo&quot;:81,&quot;parentMenuNo&quot;:1,&quot;label&quot;:&quot;Subjects&quot;,&quot;url&quot;:&quot;/page/subjects&quot;,&quot;orderNo&quot;:2,&quot;children&quot;:[{&quot;menuNo&quot;:119,&quot;parentMenuNo&quot;:81,&quot;label&quot;:&quot;Careers&quot;,&quot;url&quot;:&quot;/tag/careers&quot;,&quot;orderNo&quot;:0},{&quot;menuNo&quot;:95,&quot;parentMenuNo&quot;:81,&quot;label&quot;:&quot;Cell &amp; Molecular Biology&quot;,&quot;url&quot;:&quot;/tag/cell-molecular-biology&quot;,&quot;orderNo&quot;:1},{&quot;menuNo&quot;:144,&quot;parentMenuNo&quot;:81,&quot;label&quot;:&quot;Clinical Research&quot;,&quot;url&quot;:&quot;/tag/clinical-research&quot;,&quot;orderNo&quot;:2},{&quot;menuNo&quot;:152,&quot;parentMenuNo&quot;:81,&quot;label&quot;:&quot;Developmental Biology&quot;,&quot;url&quot;:&quot;/tag/developmental-biology&quot;,&quot;orderNo&quot;:3},{&quot;menuNo&quot;:121,&quot;parentMenuNo&quot;:81,&quot;label&quot;:&quot;Disease &amp; Medicine&quot;,&quot;url&quot;:&quot;/tag/disease-medicine&quot;,&quot;orderNo&quot;:4},{&quot;menuNo&quot;:122,&quot;parentMenuNo&quot;:81,&quot;label&quot;:&quot;Ecology &amp; Environment&quot;,&quot;url&quot;:&quot;/tag/ecology-environment&quot;,&quot;orderNo&quot;:5},{&quot;menuNo&quot;:123,&quot;parentMenuNo&quot;:81,&quot;label&quot;:&quot;Evolution&quot;,&quot;url&quot;:&quot;/tag/evolution&quot;,&quot;orderNo&quot;:6},{&quot;menuNo&quot;:124,&quot;parentMenuNo&quot;:81,&quot;label&quot;:&quot;Genetics &amp; Genomics&quot;,&quot;url&quot;:&quot;/tag/genetics-genomics&quot;,&quot;orderNo&quot;:7},{&quot;menuNo&quot;:150,&quot;parentMenuNo&quot;:81,&quot;label&quot;:&quot;History&quot;,&quot;url&quot;:&quot;/tag/history&quot;,&quot;orderNo&quot;:8},{&quot;menuNo&quot;:143,&quot;parentMenuNo&quot;:81,&quot;label&quot;:&quot;Immunology&quot;,&quot;url&quot;:&quot;/tag/immunology&quot;,&quot;orderNo&quot;:9},{&quot;menuNo&quot;:125,&quot;parentMenuNo&quot;:81,&quot;label&quot;:&quot;Microbiology&quot;,&quot;url&quot;:&quot;/tag/microbiology&quot;,&quot;orderNo&quot;:10},{&quot;menuNo&quot;:126,&quot;parentMenuNo&quot;:81,&quot;label&quot;:&quot;Neuroscience&quot;,&quot;url&quot;:&quot;/tag/neuroscience&quot;,&quot;orderNo&quot;:11},{&quot;menuNo&quot;:142,&quot;parentMenuNo&quot;:81,&quot;label&quot;:&quot;Obituaries&quot;,&quot;url&quot;:&quot;/tag/obituaries&quot;,&quot;orderNo&quot;:12},{&quot;menuNo&quot;:151,&quot;parentMenuNo&quot;:81,&quot;label&quot;:&quot;Paleontology&quot;,&quot;url&quot;:&quot;/tag/paleontology&quot;,&quot;orderNo&quot;:13},{&quot;menuNo&quot;:141,&quot;parentMenuNo&quot;:81,&quot;label&quot;:&quot;Pharma &amp; Biotech&quot;,&quot;url&quot;:&quot;/tag/pharma-biotech&quot;,&quot;orderNo&quot;:14},{&quot;menuNo&quot;:127,&quot;parentMenuNo&quot;:81,&quot;label&quot;:&quot;Policy&quot;,&quot;url&quot;:&quot;/tag/policy&quot;,&quot;orderNo&quot;:15},{&quot;menuNo&quot;:140,&quot;parentMenuNo&quot;:81,&quot;label&quot;:&quot;Profile&quot;,&quot;url&quot;:&quot;/tag/profile&quot;,&quot;orderNo&quot;:16},{&quot;menuNo&quot;:139,&quot;parentMenuNo&quot;:81,&quot;label&quot;:&quot;Publishing&quot;,&quot;url&quot;:&quot;/tag/publishing&quot;,&quot;orderNo&quot;:17},{&quot;menuNo&quot;:138,&quot;parentMenuNo&quot;:81,&quot;label&quot;:&quot;Research Integrity&quot;,&quot;url&quot;:&quot;/tag/research-integrity&quot;,&quot;orderNo&quot;:18},{&quot;menuNo&quot;:130,&quot;parentMenuNo&quot;:81,&quot;label&quot;:&quot;Techniques&quot;,&quot;url&quot;:&quot;/tag/techniques&quot;,&quot;orderNo&quot;:19}]},{&quot;menuNo&quot;:78,&quot;parentMenuNo&quot;:1,&quot;label&quot;:&quot;Multimedia&quot;,&quot;url&quot;:&quot;/page/multimedia&quot;,&quot;orderNo&quot;:3,&quot;children&quot;:[{&quot;menuNo&quot;:85,&quot;parentMenuNo&quot;:78,&quot;label&quot;:&quot;Infographics&quot;,&quot;url&quot;:&quot;/infographics&quot;,&quot;orderNo&quot;:0},{&quot;menuNo&quot;:117,&quot;parentMenuNo&quot;:78,&quot;label&quot;:&quot;&lt;em&gt;Sponsored Videos&lt;/em&gt;&quot;,&quot;url&quot;:&quot;/sponsored-videos&quot;,&quot;orderNo&quot;:1},{&quot;menuNo&quot;:88,&quot;parentMenuNo&quot;:78,&quot;label&quot;:&quot;Image of the Day&quot;,&quot;url&quot;:&quot;/tag/image-of-the-day&quot;,&quot;orderNo&quot;:2},{&quot;menuNo&quot;:146,&quot;parentMenuNo&quot;:78,&quot;label&quot;:&quot;&lt;em&gt;Sponsored Webinars&lt;/em&gt;&quot;,&quot;url&quot;:&quot;/sponsored-webinars&quot;,&quot;orderNo&quot;:3},{&quot;menuNo&quot;:133,&quot;parentMenuNo&quot;:78,&quot;label&quot;:&quot;Crossword Puzzles&quot;,&quot;url&quot;:&quot;/tag/crossword-puzzles&quot;,&quot;orderNo&quot;:4},{&quot;menuNo&quot;:147,&quot;parentMenuNo&quot;:78,&quot;label&quot;:&quot;&lt;em&gt;Sponsored Quizzes&lt;/em&gt;&quot;,&quot;url&quot;:&quot;/sponsored-quiz&quot;,&quot;orderNo&quot;:5},{&quot;menuNo&quot;:87,&quot;parentMenuNo&quot;:78,&quot;label&quot;:&quot;Videos&quot;,&quot;url&quot;:&quot;/videos&quot;,&quot;orderNo&quot;:6},{&quot;menuNo&quot;:149,&quot;parentMenuNo&quot;:78,&quot;label&quot;:&quot;&lt;em&gt;Sponsored eBooks&lt;/em&gt;&quot;,&quot;url&quot;:&quot;/sponsored-ebooks&quot;,&quot;orderNo&quot;:7},{&quot;menuNo&quot;:153,&quot;parentMenuNo&quot;:78,&quot;label&quot;:&quot;&lt;em&gt;TechEdge&lt;/em&gt;&quot;,&quot;url&quot;:&quot;/techedge&quot;,&quot;orderNo&quot;:8},{&quot;menuNo&quot;:148,&quot;parentMenuNo&quot;:78,&quot;label&quot;:&quot;&lt;em&gt;Sponsored Infographics&lt;/em&gt;&quot;,&quot;url&quot;:&quot;/sponsored-infographics&quot;,&quot;orderNo&quot;:9}]},{&quot;menuNo&quot;:80,&quot;parentMenuNo&quot;:1,&quot;label&quot;:&quot;Careers&quot;,&quot;url&quot;:&quot;/page/careers&quot;,&quot;orderNo&quot;:4,&quot;children&quot;:[{&quot;menuNo&quot;:89,&quot;parentMenuNo&quot;:80,&quot;label&quot;:&quot;Articles&quot;,&quot;url&quot;:&quot;/tag/careers&quot;,&quot;orderNo&quot;:0},{&quot;menuNo&quot;:90,&quot;parentMenuNo&quot;:80,&quot;label&quot;:&quot;Job Listings&quot;,&quot;url&quot;:&quot;http://careers.the-scientist.com/&quot;,&quot;orderNo&quot;:1},{&quot;menuNo&quot;:145,&quot;parentMenuNo&quot;:80,&quot;label&quot;:&quot;Salary Survey&quot;,&quot;url&quot;:&quot;/page/salary-survey&quot;,&quot;orderNo&quot;:2}]}]},{&quot;menuNo&quot;:2,&quot;parentMenuNo&quot;:0,&quot;label&quot;:&quot;Facebook Pages&quot;,&quot;url&quot;:&quot;/&quot;,&quot;orderNo&quot;:2,&quot;children&quot;:[{&quot;menuNo&quot;:96,&quot;parentMenuNo&quot;:2,&quot;label&quot;:&quot;The Scientist&quot;,&quot;url&quot;:&quot;https://www.facebook.com/TheScientistMagazine&quot;,&quot;orderNo&quot;:0},{&quot;menuNo&quot;:97,&quot;parentMenuNo&quot;:2,&quot;label&quot;:&quot;The Scientist Careers&quot;,&quot;url&quot;:&quot;https://www.facebook.com/TheScientistCareers&quot;,&quot;orderNo&quot;:1},{&quot;menuNo&quot;:98,&quot;parentMenuNo&quot;:2,&quot;label&quot;:&quot;Neuroscience News and Research&quot;,&quot;url&quot;:&quot;https://www.facebook.com/NeuroNewsResearch&quot;,&quot;orderNo&quot;:2},{&quot;menuNo&quot;:99,&quot;parentMenuNo&quot;:2,&quot;label&quot;:&quot;Genetics in Life Science&quot;,&quot;url&quot;:&quot;https://www.facebook.com/GeneticsInLifeScience&quot;,&quot;orderNo&quot;:3},{&quot;menuNo&quot;:100,&quot;parentMenuNo&quot;:2,&quot;label&quot;:&quot;Biology Brief&quot;,&quot;url&quot;:&quot;https://www.facebook.com/BiologyBrief&quot;,&quot;orderNo&quot;:4},{&quot;menuNo&quot;:101,&quot;parentMenuNo&quot;:2,&quot;label&quot;:&quot;Biochemistry &amp; Chemistry&quot;,&quot;url&quot;:&quot;https://www.facebook.com/BiochemistryandChemistry&quot;,&quot;orderNo&quot;:5},{&quot;menuNo&quot;:102,&quot;parentMenuNo&quot;:2,&quot;label&quot;:&quot;Bench to Bedside&quot;,&quot;url&quot;:&quot;https://www.facebook.com/Benchtobedside1&quot;,&quot;orderNo&quot;:6},{&quot;menuNo&quot;:103,&quot;parentMenuNo&quot;:2,&quot;label&quot;:&quot;Cell Biology Research&quot;,&quot;url&quot;:&quot;https://www.facebook.com/CellBiologyResearch&quot;,&quot;orderNo&quot;:7},{&quot;menuNo&quot;:104,&quot;parentMenuNo&quot;:2,&quot;label&quot;:&quot;Microbiology and Immunology&quot;,&quot;url&quot;:&quot;https://www.facebook.com/MicrobiologyAndImmunology&quot;,&quot;orderNo&quot;:8},{&quot;menuNo&quot;:105,&quot;parentMenuNo&quot;:2,&quot;label&quot;:&quot;Cancer Research News&quot;,&quot;url&quot;:&quot;https://www.facebook.com/CancerResearchNews/&quot;,&quot;orderNo&quot;:9},{&quot;menuNo&quot;:106,&quot;parentMenuNo&quot;:2,&quot;label&quot;:&quot;Stem Cell and Regenerative Science&quot;,&quot;url&quot;:&quot;https://www.facebook.com/StemCellAndRegenerativeScience&quot;,&quot;orderNo&quot;:1000},{&quot;menuNo&quot;:107,&quot;parentMenuNo&quot;:2,&quot;label&quot;:&quot;The NeuroScientist&quot;,&quot;url&quot;:&quot;https://www.facebook.com/TheNeuroScientist/&quot;,&quot;orderNo&quot;:1000}]},{&quot;menuNo&quot;:3,&quot;parentMenuNo&quot;:0,&quot;label&quot;:&quot;Footer Navigation&quot;,&quot;url&quot;:&quot;/&quot;,&quot;orderNo&quot;:3,&quot;children&quot;:[{&quot;menuNo&quot;:108,&quot;parentMenuNo&quot;:3,&quot;label&quot;:&quot;About &amp; Contact&quot;,&quot;url&quot;:&quot;/about&quot;,&quot;orderNo&quot;:1},{&quot;menuNo&quot;:109,&quot;parentMenuNo&quot;:3,&quot;label&quot;:&quot;Privacy Policy &quot;,&quot;url&quot;:&quot;/privacy-policy&quot;,&quot;orderNo&quot;:2},{&quot;menuNo&quot;:110,&quot;parentMenuNo&quot;:3,&quot;label&quot;:&quot;Job Listings&quot;,&quot;url&quot;:&quot;http://careers.the-scientist.com/&quot;,&quot;orderNo&quot;:3},{&quot;menuNo&quot;:111,&quot;parentMenuNo&quot;:3,&quot;label&quot;:&quot;Subscribe&quot;,&quot;url&quot;:&quot;/subscribe&quot;,&quot;orderNo&quot;:4},{&quot;menuNo&quot;:112,&quot;parentMenuNo&quot;:3,&quot;label&quot;:&quot;Advertise&quot;,&quot;url&quot;:&quot;/advertise&quot;,&quot;orderNo&quot;:5}]}]" data-signin="false"></div><div id="MenusDesktop"><div id="SignInAndSearch" data-signin="false" data-search="true" data-mobile="false"><div class="searchbar"><form action="/search" method="get"><div class="input-btn-group"><input id="siteSearchInputDesktop" type="text" name="for" placeholder="Search"><button class="uppercase">Search</button></div></form></div></div><nav><div class="dropdown"><li><a class="navItem" href="/news-opinion">News & Opinion</a></li></div><div class="dropdown"><li><a class="navItem" href="/magazine/current-issue">Magazine</a></li><div class="dropdown-content col-1"><li><a class="subNavItem" href="/magazine/current-issue">Current Issue</a></li><li><a class="subNavItem" href="/magazine">Archives</a></li><li><a class="subNavItem" href="/features">Features</a></li><li><a class="subNavItem" href="/infographics">Infographics</a></li><li><a class="subNavItem" href="/page/top-10-innovations">Top 10 Innovations</a></li></div></div><div class="dropdown"><li><a class="navItem" href="/page/subjects">Subjects</a></li><div class="dropdown-content col-3"><li><a class="subNavItem" href="/tag/careers">Careers</a></li><li><a class="subNavItem" href="/tag/cell-molecular-biology">Cell & Molecular Biology</a></li><li><a class="subNavItem" href="/tag/clinical-research">Clinical Research</a></li><li><a class="subNavItem" href="/tag/developmental-biology">Developmental Biology</a></li><li><a class="subNavItem" href="/tag/disease-medicine">Disease & Medicine</a></li><li><a class="subNavItem" href="/tag/ecology-environment">Ecology & Environment</a></li><li><a class="subNavItem" href="/tag/evolution">Evolution</a></li><li><a class="subNavItem" href="/tag/genetics-genomics">Genetics & Genomics</a></li><li><a class="subNavItem" href="/tag/history">History</a></li><li><a class="subNavItem" href="/tag/immunology">Immunology</a></li><li><a class="subNavItem" href="/tag/microbiology">Microbiology</a></li><li><a class="subNavItem" href="/tag/neuroscience">Neuroscience</a></li><li><a class="subNavItem" href="/tag/obituaries">Obituaries</a></li><li><a class="subNavItem" href="/tag/paleontology">Paleontology</a></li><li><a class="subNavItem" href="/tag/pharma-biotech">Pharma & Biotech</a></li><li><a class="subNavItem" href="/tag/policy">Policy</a></li><li><a class="subNavItem" href="/tag/profile">Profile</a></li><li><a class="subNavItem" href="/tag/publishing">Publishing</a></li><li><a class="subNavItem" href="/tag/research-integrity">Research Integrity</a></li><li><a class="subNavItem" href="/tag/techniques">Techniques</a></li></div></div><div class="dropdown"><li><a class="navItem" href="/page/multimedia">Multimedia</a></li><div class="dropdown-content col-2"><li><a class="subNavItem" href="/infographics">Infographics</a></li><li><a class="subNavItem" href="/sponsored-videos"><em>Sponsored Videos</em></a></li><li><a class="subNavItem" href="/tag/image-of-the-day">Image of the Day</a></li><li><a class="subNavItem" href="/sponsored-webinars"><em>Sponsored Webinars</em></a></li><li><a class="subNavItem" href="/tag/crossword-puzzles">Crossword Puzzles</a></li><li><a class="subNavItem" href="/sponsored-quiz"><em>Sponsored Quizzes</em></a></li><li><a class="subNavItem" href="/videos">Videos</a></li><li><a class="subNavItem" href="/sponsored-ebooks"><em>Sponsored eBooks</em></a></li><li><a class="subNavItem" href="/techedge"><em>TechEdge</em></a></li><li><a class="subNavItem" href="/sponsored-infographics"><em>Sponsored Infographics</em></a></li></div></div><div class="dropdown"><li><a class="navItem" href="/page/careers">Careers</a></li><div class="dropdown-content col-1"><li><a class="subNavItem" href="/tag/careers">Articles</a></li><li><a class="subNavItem" href="http://careers.the-scientist.com/">Job Listings</a></li><li><a class="subNavItem" href="/page/salary-survey">Salary Survey</a></li></div></div><div class="dropdown"><li><a class="navItem inverted" href="/subscribe">Subscribe</a></li></div></nav></div></div></div></header><div id="MainContainer"><section class="advertisement" data-zone="TS_WEB_ROS_LEADERBOARD_NULL_728X90" id="ts-web-ros-leaderboard-null-728x90"></section><div id="Hero"><div class="slide"><div class="hero articleView"><div class="heroContent"><div class="heroImg"><picture><source media="(max-width: 399px)" srcset="https://cdn.the-scientist.com/assets/articleNo/65323/hImg/30256/infusion-banner-s.png"/><source media="(max-width: 799px)" srcset="https://cdn.the-scientist.com/assets/articleNo/65323/hImg/30256/infusion-banner-m.png"/><source media="(max-width: 1199px)" srcset="https://cdn.the-scientist.com/assets/articleNo/65323/hImg/30256/infusion-banner-l.png"/><source media="(min-width: 1200px)" srcset="https://cdn.the-scientist.com/assets/articleNo/65323/hImg/30256/infusion-banner-x.png"/><img src="https://cdn.the-scientist.com/assets/articleNo/65323/hImg/30256/infusion-banner-s.png" alt="More Cancer Mutations, Better Immunotherapy Outcomes" title="More Cancer Mutations, Better Immunotherapy Outcomes"/></picture></div></div></div><div class="articleImg"><picture><source media="(max-width: 399px)" srcset="https://cdn.the-scientist.com/assets/articleNo/65323/aImg/30255/infusion-s.png"/><source media="(min-width: 400px)" srcset="https://cdn.the-scientist.com/assets/articleNo/65323/aImg/30255/infusion-m.png"/><img src="https://cdn.the-scientist.com/assets/articleNo/65323/aImg/30255/infusion-s.png" alt="More Cancer Mutations, Better Immunotherapy Outcomes" title="More Cancer Mutations, Better Immunotherapy Outcomes"/></picture></div></div></div><div class="main-container" id="MainContent"><div id="Content"><main class="Featured Hero" id="ArticleView"><header class="overlay-header"><ol class="breadcrumbs"><li><a class="capitalize" href="/">Home</a></li><li><a class="capitalize" href="/news-opinion">News & Opinion</a></li></ol><h1 class="text-white">More Cancer Mutations, Better Immunotherapy Outcomes</h1></header><div class="articleWrapper"><article><header><h2>Immune checkpoint inhibitors are generally most effective against tumors with more genetic mutations, according to a new study, although the relationship isn&rsquo;t true for all cancers.</h2><div class="extras"><div class="text"><h6 class="italic text-placeholder">Jan 15, 2019</h6><h5 class="uppercase">Catherine Offord</h5></div><div class="addthis_sharing_toolbox"></div></div></header><main class="font-secondary fr-view" id="ArticleBody"><p class="fr-hero-header-caption fr-caption fr-right fr-quarter">ABOVE: &copy; ISTOCK.COM, <a href="https://www.istockphoto.com/photo/group-of-doctors-in-a-hurry-down-the-hospital-hallway-gm856544984-141125935" rel="noopener noreferrer" target="_blank">SUDOK1</a></p><p><span class="dropcap">T</span>he number of mutations in a tumor&rsquo;s genome may predict how well a patient will benefit from treatment with immune checkpoint inhibitors, drugs that take the brakes off the immune system, according to a largescale study published yesterday (January 14) in <em><a href="https://www.nature.com/articles/s41588-018-0312-8" rel="noopener noreferrer" target="_blank">Nature Genetics</a></em>. Although previous research has already indicated that higher tumor mutational burden (TMB) is tied to better treatment outcomes, the current work, which includes data from more than 1,600 patients across multiple cancer types, provides some of the strongest and most detailed evidence for the link yet.</p><p>Checkpoint inhibitor drugs work by blocking protein receptors that regulate the activity of T cells and other immune system components, thus boosting these cells&rsquo; antitumor activity. Bristol-Myers Squibb&rsquo;s nivolumab (Opdivo) and Merck&rsquo;s pembrolizumab (Keytruda) have made progress in clinical trials of late, with the latter therapy receiving regulatory approval from the US Food and Drug Administration in 2018.</p><h3>See &ldquo;<a href="https://www.the-scientist.com/the-scientist/immunotherapy-drug-shows-promise-for-melanoma-lung-cancer-41892" rel="noopener noreferrer" target="_blank">Immunotherapy Drug Shows Promise for Melanoma, Lung Cancer</a>&rdquo;</h3><p>Variation in patients&rsquo; responses to these drugs has led researchers to search for ways to predict who will benefit from which intervention. &ldquo;Given the potential toxicities of immunotherapy and the highly variable response to [immune checkpoint inhibitors], as well as the significant economic cost of these agents, there is an urgent need for biomarkers that can predict immunotherapy response,&rdquo; the researchers write in their paper.&nbsp;</p><p>In the current study, a team of scientists led by Luc Morris of Memorial Sloan Kettering Cancer Center in New York City analyzed clinical information and DNA sequence data from 1,662 patients with advanced cancer who had been treated with checkpoint inhibitors. They found that, in general, people with a higher TMB responded better to the drugs than those with a lower mutational burden, although the relationship varied substantially across tumors. In glioma, for example, patients with a higher TMB didn&rsquo;t show any advantage over those with a lower TMB.</p><h3>See &ldquo;<a href="https://www.the-scientist.com/daily-news/the-cancer-genes-needed-for-immunotherapy-response-31122" rel="noopener noreferrer" target="_blank">The Cancer Genes Needed for Immunotherapy Response</a>&rdquo;</h3><p>It&rsquo;s not yet clear why more tumor mutations are linked with improved treatment outcomes. One popular theory is that a higher TMB makes a tumor cell appear more different from a normal cell by creating an abundance of abnormal proteins, which the immune system then recognizes and reads as a signal to destroy the tumor.</p><p>Whatever the explanation, Morris notes that using TMB as a biomarker could help clinicians predict the outcome of checkpoint inhibitor therapies. &ldquo;Only in lung cancer is TMB being used in a clinical trial,&rdquo; he tells <em><a href="https://www.forbes.com/sites/victoriaforster/2019/01/14/researchers-uncover-major-clue-to-predicting-response-to-immunotherapy/" rel="noopener noreferrer" target="_blank">Forbes</a></em>. &ldquo;Hopefully this data will give us permission to include it in future clinical trials on other cancer types.&rdquo;</p><p>However, he adds that TMB is just &ldquo;one biomarker for response, but a number of other factors are important. I would not suggest you take the data from this paper and apply it to a patient in the clinic.&rdquo;</p><h3>See &ldquo;<a href="https://www.the-scientist.com/critic-at-large/opinion--learning-from-immunotherapys-recent-failures-64575" rel="noopener noreferrer" target="_blank">Opinion: Learning from Immunotherapy&rsquo;s Recent Failures</a>&rdquo;</h3></main><footer><div class="CategoriesAndTags"><h3>Keywords:</h3><div class="TagList listed-items"><a class="no-wrap-text" href="/tag/cancer"><h5 class="inline-block text-primary">cancer</h5></a><a class="no-wrap-text" href="/tag/cancer-immunotherapy"><h5 class="inline-block text-primary">cancer immunotherapy</h5></a><a class="no-wrap-text" href="/tag/checkpoint-inhibitor"><h5 class="inline-block text-primary">checkpoint inhibitor</h5></a><a class="no-wrap-text" href="/tag/clinical-research"><h5 class="inline-block text-primary">clinical research</h5></a><a class="no-wrap-text" href="/tag/disease-medicine"><h5 class="inline-block text-primary">disease &amp; medicine</h5></a><a class="no-wrap-text" href="/tag/genetics-genomics"><h5 class="inline-block text-primary">genetics &amp; genomics</h5></a><a class="no-wrap-text" href="/tag/immune-checkpoint"><h5 class="inline-block text-primary">immune checkpoint</h5></a><a class="no-wrap-text" href="/tag/immune-checkpoint-blocker"><h5 class="inline-block text-primary">immune checkpoint blocker</h5></a><a class="no-wrap-text" href="/tag/immunotherapy"><h5 class="inline-block text-primary">immunotherapy</h5></a><a class="no-wrap-text" href="/tag/pharma-biotech"><h5 class="inline-block text-primary">pharma &amp; biotech</h5></a><a class="no-wrap-text" href="/tag/prediction"><h5 class="inline-block text-primary">prediction</h5></a><a class="no-wrap-text" href="/tag/therapy"><h5 class="inline-block text-primary">therapy</h5></a></div></div></footer></article></div></main><section class="advertisement" data-zone="TS_WEB_ARTICLE-PAGE_SMALL-LEADERBOARD_468X60" id="ts-web-article-page-small-leaderboard-468x60"></section><div class="main-container" id="ExtraContent"><div class="full-width" id="RelatedArticles"><div class="h1">Related Articles</div><div class="articleTabList even"><div class="articleTab"><div class="articleTabImg"><a href="/news-opinion/immunotherapy-more-effective-in-men-study-64412"><img src="https://cdn.the-scientist.com/assets/articleNo/64412/aImg/27180/immunotherapy-more-effective-in-men-study-t.jpg" alt="Immunotherapy More Effective in Men: Study" title="Immunotherapy More Effective in Men: Study"/></a></div><div class="articleTabText"><a href="/news-opinion/immunotherapy-more-effective-in-men-study-64412"><div class="h3 max-2-lines l-h-3">Immunotherapy More Effective in Men: Study</div><div class="h3 max-4-lines l-h-3">Immunotherapy More Effective in Men: Study</div></a></div></div><div class="articleTab"><div class="articleTabImg"><a href="/news-opinion/taller-people-more-prone-to-cancer-64995"><img src="https://cdn.the-scientist.com/assets/articleNo/64995/aImg/29271/tall-t.jpg" alt="Taller People More Prone to Cancer" title="Taller People More Prone to Cancer"/></a></div><div class="articleTabText"><a href="/news-opinion/taller-people-more-prone-to-cancer-64995"><div class="h3 max-2-lines l-h-3">Taller People More Prone to Cancer</div><div class="h3 max-4-lines l-h-3">Taller People More Prone to Cancer</div></a></div></div><div class="articleTab"><div class="articleTabImg"><a href="/news-opinion/us-cancer-death-rate-dropped-for-25-years-starting-in-1991-65303"><img src="https://cdn.the-scientist.com/assets/articleNo/65303/aImg/30208/cancer-deaths-t.jpg" alt="US Cancer Death Rate Dropped for 25 Years Starting in 1991" title="US Cancer Death Rate Dropped for 25 Years Starting in 1991"/></a></div><div class="articleTabText"><a href="/news-opinion/us-cancer-death-rate-dropped-for-25-years-starting-in-1991-65303"><div class="h3 max-2-lines l-h-3">US Cancer Death Rate Dropped for 25 Years Starting in 1991</div><div class="h3 max-4-lines l-h-3">US Cancer Death Rate Dropped for 25 Years Starting in 1991</div></a></div></div><div class="articleTab"><div class="articleTabImg"><a href="/critic-at-large/opinion-more-biomarkers-needed-for-cancer-immunotherapy-31741"><img src="https://cdn.the-scientist.com/assets/articleNo/31741/aImg/4514/opinion-more-biomarkers-needed-for-cancer-immunotherapy-t.jpg" alt="Opinion: More Biomarkers Needed for Cancer Immunotherapy" title="Opinion: More Biomarkers Needed for Cancer Immunotherapy"/></a></div><div class="articleTabText"><a href="/critic-at-large/opinion-more-biomarkers-needed-for-cancer-immunotherapy-31741"><div class="h3 max-2-lines l-h-3">Opinion: More Biomarkers Needed for Cancer Immunotherapy</div><div class="h3 max-4-lines l-h-3">Opinion: More Biomarkers Needed for Cancer Immunotherapy</div></a></div></div></div></div></div></div><div id="Sidebar"><aside id="SidebarContent"><section class="advertisement" data-zone="TS_WEB_ROS_MEDIUM-RECTANGLE_TOP_300X250" id="ts-web-ros-medium-rectangle-top-300x250"></section><div class="socialMedia"><a class="socialMediaIcon" href="https://www.facebook.com/TheScientistMagazine" alt="Go to The Scientist's Facebook Page" title="Facebook" target="_blank"><svg aria-hidden="true" data-prefix="fas" data-icon="facebook-square" class="svg-inline--fa fa-facebook-square fa-w-16 icon-btn" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512">
<path fill="currentColor" d="M448 80v352c0 26.5-21.5 48-48 48h-85.3V302.8h60.6l8.7-67.6h-69.3V192c0-19.6 5.4-32.9 33.5-32.9H384V98.7c-6.2-.8-27.4-2.7-52.2-2.7-51.6 0-87 31.5-87 89.4v49.9H184v67.6h60.9V480H48c-26.5 0-48-21.5-48-48V80c0-26.5 21.5-48 48-48h352c26.5 0 48 21.5 48 48z"></path>
</svg></a><a class="socialMediaIcon" href="https://twitter.com/TheScientistLLC" alt="Go to The Scientist's Twitter Page" title="Twitter" target="_blank"><svg aria-hidden="true" data-prefix="fas" data-icon="twitter-square" class="svg-inline--fa fa-twitter-square fa-w-16 icon-btn" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512">
<path fill="currentColor" d="M400 32H48C21.5 32 0 53.5 0 80v352c0 26.5 21.5 48 48 48h352c26.5 0 48-21.5 48-48V80c0-26.5-21.5-48-48-48zm-48.9 158.8c.2 2.8.2 5.7.2 8.5 0 86.7-66 186.6-186.6 186.6-37.2 0-71.7-10.8-100.7-29.4 5.3.6 10.4.8 15.8.8 30.7 0 58.9-10.4 81.4-28-28.8-.6-53-19.5-61.3-45.5 10.1 1.5 19.2 1.5 29.6-1.2-30-6.1-52.5-32.5-52.5-64.4v-.8c8.7 4.9 18.9 7.9 29.6 8.3a65.447 65.447 0 0 1-29.2-54.6c0-12.2 3.2-23.4 8.9-33.1 32.3 39.8 80.8 65.8 135.2 68.6-9.3-44.5 24-80.6 64-80.6 18.9 0 35.9 7.9 47.9 20.7 14.8-2.8 29-8.3 41.6-15.8-4.9 15.2-15.2 28-28.8 36.1 13.2-1.4 26-5.1 37.8-10.2-8.9 13.1-20.1 24.7-32.9 34z"></path>
</svg></a><a class="socialMediaIcon" href="https://www.instagram.com/the_scientist_magazine/" alt="Go to The Scientist's Instagram Page" title="Instagram" target="_blank"><svg aria-hidden="true" data-prefix="fas" data-icon="instagram" class="svg-inline--fa fa-instagram fa-w-16 icon-btn" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512">
<path fill="currentColor" d="M224.1 141c-63.6 0-114.9 51.3-114.9 114.9s51.3 114.9 114.9 114.9S339 319.5 339 255.9 287.7 141 224.1 141zm0 189.6c-41.1 0-74.7-33.5-74.7-74.7s33.5-74.7 74.7-74.7 74.7 33.5 74.7 74.7-33.6 74.7-74.7 74.7zm146.4-194.3c0 14.9-12 26.8-26.8 26.8-14.9 0-26.8-12-26.8-26.8s12-26.8 26.8-26.8 26.8 12 26.8 26.8zm76.1 27.2c-1.7-35.9-9.9-67.7-36.2-93.9-26.2-26.2-58-34.4-93.9-36.2-37-2.1-147.9-2.1-184.9 0-35.8 1.7-67.6 9.9-93.9 36.1s-34.4 58-36.2 93.9c-2.1 37-2.1 147.9 0 184.9 1.7 35.9 9.9 67.7 36.2 93.9s58 34.4 93.9 36.2c37 2.1 147.9 2.1 184.9 0 35.9-1.7 67.7-9.9 93.9-36.2 26.2-26.2 34.4-58 36.2-93.9 2.1-37 2.1-147.8 0-184.8zM398.8 388c-7.8 19.6-22.9 34.7-42.6 42.6-29.5 11.7-99.5 9-132.1 9s-102.7 2.6-132.1-9c-19.6-7.8-34.7-22.9-42.6-42.6-11.7-29.5-9-99.5-9-132.1s-2.6-102.7 9-132.1c7.8-19.6 22.9-34.7 42.6-42.6 29.5-11.7 99.5-9 132.1-9s102.7-2.6 132.1 9c19.6 7.8 34.7 22.9 42.6 42.6 11.7 29.5 9 99.5 9 132.1s2.7 102.7-9 132.1z"></path>
</svg></a><a class="socialMediaIcon" href="https://www.linkedin.com/company/the-scientist" alt="Go to The Scientist's LinkedIn Page" title="LinkedIn" target="_blank"><svg aria-hidden="true" data-prefix="fas" data-icon="linkedin" class="svg-inline--fa fa-linkedin fa-w-16 icon-btn" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512">
<path fill="currentColor" d="M416 32H31.9C14.3 32 0 46.5 0 64.3v383.4C0 465.5 14.3 480 31.9 480H416c17.6 0 32-14.5 32-32.3V64.3c0-17.8-14.4-32.3-32-32.3zM135.4 416H69V202.2h66.5V416zm-33.2-243c-21.3 0-38.5-17.3-38.5-38.5S80.9 96 102.2 96c21.2 0 38.5 17.3 38.5 38.5 0 21.3-17.2 38.5-38.5 38.5zm282.1 243h-66.4V312c0-24.8-.5-56.7-34.5-56.7-34.6 0-39.9 27-39.9 54.9V416h-66.4V202.2h63.7v29.2h.9c8.9-16.8 30.6-34.5 62.9-34.5 67.2 0 79.7 44.3 79.7 101.9V416z"></path>
</svg></a><a class="socialMediaIcon" href="https://www.youtube.com/user/TheScientistLLC" alt="Go to The Scientist's YouTube Page" title="YouTube" target="_blank"><svg aria-hidden="true" data-prefix="fas" data-icon="youtube-square" class="svg-inline--fa fa-youtube-square fa-w-16 icon-btn" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512">
<path fill="currentColor" d="M186.8 202.1l95.2 54.1-95.2 54.1V202.1zM448 80v352c0 26.5-21.5 48-48 48H48c-26.5 0-48-21.5-48-48V80c0-26.5 21.5-48 48-48h352c26.5 0 48 21.5 48 48zm-42 176.3s0-59.6-7.6-88.2c-4.2-15.8-16.5-28.2-32.2-32.4C337.9 128 224 128 224 128s-113.9 0-142.2 7.7c-15.7 4.2-28 16.6-32.2 32.4-7.6 28.5-7.6 88.2-7.6 88.2s0 59.6 7.6 88.2c4.2 15.8 16.5 27.7 32.2 31.9C110.1 384 224 384 224 384s113.9 0 142.2-7.7c15.7-4.2 28-16.1 32.2-31.9 7.6-28.5 7.6-88.1 7.6-88.1z"></path>
</svg></a><a class="socialMediaIcon" href="https://vimeo.com/thescientistllc" alt="Go to The Scientist's Vimeo Page" title="Vimeo" target="_blank"><svg aria-hidden="true" data-prefix="fas" data-icon="vimeo-square" class="svg-inline--fa fa-vimeo-square fa-w-16 icon-btn" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512">
<path fill="currentColor" d="M400 32H48C21.5 32 0 53.5 0 80v352c0 26.5 21.5 48 48 48h352c26.5 0 48-21.5 48-48V80c0-26.5-21.5-48-48-48zm-16.2 149.6c-1.4 31.1-23.2 73.8-65.3 127.9-43.5 56.5-80.3 84.8-110.4 84.8-18.7 0-34.4-17.2-47.3-51.6-25.2-92.3-35.9-146.4-56.7-146.4-2.4 0-10.8 5-25.1 15.1L64 192c36.9-32.4 72.1-68.4 94.1-70.4 24.9-2.4 40.2 14.6 46 51.1 20.5 129.6 29.6 149.2 66.8 90.5 13.4-21.2 20.6-37.2 21.5-48.3 3.4-32.8-25.6-30.6-45.2-22.2 15.7-51.5 45.8-76.5 90.1-75.1 32.9 1 48.4 22.4 46.5 64z"></path>
</svg></a></div><div id="Trending"></div><section class="advertisement" data-zone="TS_WEB_ROS_MEDIUM-RECTANGLE_MIDDLE_300X250" id="ts-web-ros-medium-rectangle-middle-300x250"></section><section class="advertisement" data-zone="TS_WEB_ROS_MEDIUM-RECTANGLE_BOTTOM_300X250" id="ts-web-ros-medium-rectangle-bottom-300x250"></section></aside></div></div><div id="CurrentIssue"></div><section class="advertisement" data-zone="TS_WEB_ROS_LEADERBOARD_BOTTOM_728X90" id="ts-web-ros-leaderboard-bottom-728x90"></section><div id="Sponsored"></div><div id="Marketplace"></div><footer id="MainFooter"><div class="main-container"><header><div class="h1">Stay Connected with</div><div class="logo"></div></header><div id="NewsletterSignUp"><h4 class="text-primary">E-Newsletter Sign-up</h4><script charset="utf-8" type="text/javascript" src="//js.hsforms.net/forms/v2.js"></script><script>hbspt.forms.create({
    portalId: "547446",
    formId: "c78de44f-4cf1-4a5b-a472-b462a5916120",
    css: ""
});</script></div><div class="socialMedia"><a class="socialMediaIcon" href="https://www.facebook.com/TheScientistMagazine" alt="Go to The Scientist's Facebook Page" title="Facebook" target="_blank"><svg aria-hidden="true" data-prefix="fas" data-icon="facebook-square" class="svg-inline--fa fa-facebook-square fa-w-16 icon-btn" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512">
<path fill="currentColor" d="M448 80v352c0 26.5-21.5 48-48 48h-85.3V302.8h60.6l8.7-67.6h-69.3V192c0-19.6 5.4-32.9 33.5-32.9H384V98.7c-6.2-.8-27.4-2.7-52.2-2.7-51.6 0-87 31.5-87 89.4v49.9H184v67.6h60.9V480H48c-26.5 0-48-21.5-48-48V80c0-26.5 21.5-48 48-48h352c26.5 0 48 21.5 48 48z"></path>
</svg></a><a class="socialMediaIcon" href="https://twitter.com/TheScientistLLC" alt="Go to The Scientist's Twitter Page" title="Twitter" target="_blank"><svg aria-hidden="true" data-prefix="fas" data-icon="twitter-square" class="svg-inline--fa fa-twitter-square fa-w-16 icon-btn" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512">
<path fill="currentColor" d="M400 32H48C21.5 32 0 53.5 0 80v352c0 26.5 21.5 48 48 48h352c26.5 0 48-21.5 48-48V80c0-26.5-21.5-48-48-48zm-48.9 158.8c.2 2.8.2 5.7.2 8.5 0 86.7-66 186.6-186.6 186.6-37.2 0-71.7-10.8-100.7-29.4 5.3.6 10.4.8 15.8.8 30.7 0 58.9-10.4 81.4-28-28.8-.6-53-19.5-61.3-45.5 10.1 1.5 19.2 1.5 29.6-1.2-30-6.1-52.5-32.5-52.5-64.4v-.8c8.7 4.9 18.9 7.9 29.6 8.3a65.447 65.447 0 0 1-29.2-54.6c0-12.2 3.2-23.4 8.9-33.1 32.3 39.8 80.8 65.8 135.2 68.6-9.3-44.5 24-80.6 64-80.6 18.9 0 35.9 7.9 47.9 20.7 14.8-2.8 29-8.3 41.6-15.8-4.9 15.2-15.2 28-28.8 36.1 13.2-1.4 26-5.1 37.8-10.2-8.9 13.1-20.1 24.7-32.9 34z"></path>
</svg></a><a class="socialMediaIcon" href="https://www.instagram.com/the_scientist_magazine/" alt="Go to The Scientist's Instagram Page" title="Instagram" target="_blank"><svg aria-hidden="true" data-prefix="fas" data-icon="instagram" class="svg-inline--fa fa-instagram fa-w-16 icon-btn" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512">
<path fill="currentColor" d="M224.1 141c-63.6 0-114.9 51.3-114.9 114.9s51.3 114.9 114.9 114.9S339 319.5 339 255.9 287.7 141 224.1 141zm0 189.6c-41.1 0-74.7-33.5-74.7-74.7s33.5-74.7 74.7-74.7 74.7 33.5 74.7 74.7-33.6 74.7-74.7 74.7zm146.4-194.3c0 14.9-12 26.8-26.8 26.8-14.9 0-26.8-12-26.8-26.8s12-26.8 26.8-26.8 26.8 12 26.8 26.8zm76.1 27.2c-1.7-35.9-9.9-67.7-36.2-93.9-26.2-26.2-58-34.4-93.9-36.2-37-2.1-147.9-2.1-184.9 0-35.8 1.7-67.6 9.9-93.9 36.1s-34.4 58-36.2 93.9c-2.1 37-2.1 147.9 0 184.9 1.7 35.9 9.9 67.7 36.2 93.9s58 34.4 93.9 36.2c37 2.1 147.9 2.1 184.9 0 35.9-1.7 67.7-9.9 93.9-36.2 26.2-26.2 34.4-58 36.2-93.9 2.1-37 2.1-147.8 0-184.8zM398.8 388c-7.8 19.6-22.9 34.7-42.6 42.6-29.5 11.7-99.5 9-132.1 9s-102.7 2.6-132.1-9c-19.6-7.8-34.7-22.9-42.6-42.6-11.7-29.5-9-99.5-9-132.1s-2.6-102.7 9-132.1c7.8-19.6 22.9-34.7 42.6-42.6 29.5-11.7 99.5-9 132.1-9s102.7-2.6 132.1 9c19.6 7.8 34.7 22.9 42.6 42.6 11.7 29.5 9 99.5 9 132.1s2.7 102.7-9 132.1z"></path>
</svg></a><a class="socialMediaIcon" href="https://www.linkedin.com/company/the-scientist" alt="Go to The Scientist's LinkedIn Page" title="LinkedIn" target="_blank"><svg aria-hidden="true" data-prefix="fas" data-icon="linkedin" class="svg-inline--fa fa-linkedin fa-w-16 icon-btn" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512">
<path fill="currentColor" d="M416 32H31.9C14.3 32 0 46.5 0 64.3v383.4C0 465.5 14.3 480 31.9 480H416c17.6 0 32-14.5 32-32.3V64.3c0-17.8-14.4-32.3-32-32.3zM135.4 416H69V202.2h66.5V416zm-33.2-243c-21.3 0-38.5-17.3-38.5-38.5S80.9 96 102.2 96c21.2 0 38.5 17.3 38.5 38.5 0 21.3-17.2 38.5-38.5 38.5zm282.1 243h-66.4V312c0-24.8-.5-56.7-34.5-56.7-34.6 0-39.9 27-39.9 54.9V416h-66.4V202.2h63.7v29.2h.9c8.9-16.8 30.6-34.5 62.9-34.5 67.2 0 79.7 44.3 79.7 101.9V416z"></path>
</svg></a><a class="socialMediaIcon" href="https://www.youtube.com/user/TheScientistLLC" alt="Go to The Scientist's YouTube Page" title="YouTube" target="_blank"><svg aria-hidden="true" data-prefix="fas" data-icon="youtube-square" class="svg-inline--fa fa-youtube-square fa-w-16 icon-btn" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512">
<path fill="currentColor" d="M186.8 202.1l95.2 54.1-95.2 54.1V202.1zM448 80v352c0 26.5-21.5 48-48 48H48c-26.5 0-48-21.5-48-48V80c0-26.5 21.5-48 48-48h352c26.5 0 48 21.5 48 48zm-42 176.3s0-59.6-7.6-88.2c-4.2-15.8-16.5-28.2-32.2-32.4C337.9 128 224 128 224 128s-113.9 0-142.2 7.7c-15.7 4.2-28 16.6-32.2 32.4-7.6 28.5-7.6 88.2-7.6 88.2s0 59.6 7.6 88.2c4.2 15.8 16.5 27.7 32.2 31.9C110.1 384 224 384 224 384s113.9 0 142.2-7.7c15.7-4.2 28-16.1 32.2-31.9 7.6-28.5 7.6-88.1 7.6-88.1z"></path>
</svg></a><a class="socialMediaIcon" href="https://vimeo.com/thescientistllc" alt="Go to The Scientist's Vimeo Page" title="Vimeo" target="_blank"><svg aria-hidden="true" data-prefix="fas" data-icon="vimeo-square" class="svg-inline--fa fa-vimeo-square fa-w-16 icon-btn" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512">
<path fill="currentColor" d="M400 32H48C21.5 32 0 53.5 0 80v352c0 26.5 21.5 48 48 48h352c26.5 0 48-21.5 48-48V80c0-26.5-21.5-48-48-48zm-16.2 149.6c-1.4 31.1-23.2 73.8-65.3 127.9-43.5 56.5-80.3 84.8-110.4 84.8-18.7 0-34.4-17.2-47.3-51.6-25.2-92.3-35.9-146.4-56.7-146.4-2.4 0-10.8 5-25.1 15.1L64 192c36.9-32.4 72.1-68.4 94.1-70.4 24.9-2.4 40.2 14.6 46 51.1 20.5 129.6 29.6 149.2 66.8 90.5 13.4-21.2 20.6-37.2 21.5-48.3 3.4-32.8-25.6-30.6-45.2-22.2 15.7-51.5 45.8-76.5 90.1-75.1 32.9 1 48.4 22.4 46.5 64z"></path>
</svg></a></div><div class="facebookPages"><h4>Facebook Pages</h4><li><a class="uppercase" href="https://www.facebook.com/TheScientistMagazine" target="_blank">The Scientist</a></li><li><a class="uppercase" href="https://www.facebook.com/TheScientistCareers" target="_blank">The Scientist Careers</a></li><li><a class="uppercase" href="https://www.facebook.com/NeuroNewsResearch" target="_blank">Neuroscience News and Research</a></li><li><a class="uppercase" href="https://www.facebook.com/GeneticsInLifeScience" target="_blank">Genetics in Life Science</a></li><li><a class="uppercase" href="https://www.facebook.com/BiologyBrief" target="_blank">Biology Brief</a></li><li><a class="uppercase" href="https://www.facebook.com/BiochemistryandChemistry" target="_blank">Biochemistry &amp; Chemistry</a></li><li><a class="uppercase" href="https://www.facebook.com/Benchtobedside1" target="_blank">Bench to Bedside</a></li><li><a class="uppercase" href="https://www.facebook.com/CellBiologyResearch" target="_blank">Cell Biology Research</a></li><li><a class="uppercase" href="https://www.facebook.com/MicrobiologyAndImmunology" target="_blank">Microbiology and Immunology</a></li><li><a class="uppercase" href="https://www.facebook.com/CancerResearchNews/" target="_blank">Cancer Research News</a></li><li><a class="uppercase" href="https://www.facebook.com/StemCellAndRegenerativeScience" target="_blank">Stem Cell and Regenerative Science</a></li><li><a class="uppercase" href="https://www.facebook.com/TheNeuroScientist/" target="_blank">The NeuroScientist</a></li></div><nav><li><a class="uppercase" href="/about" target="_blank">About &amp; Contact</a></li><li><a class="uppercase" href="/privacy-policy" target="_blank">Privacy Policy </a></li><li><a class="uppercase" href="http://careers.the-scientist.com/" target="_blank">Job Listings</a></li><li><a class="uppercase" href="/subscribe" target="_blank">Subscribe</a></li><li><a class="uppercase" href="/advertise" target="_blank">Advertise</a></li></nav><div class="labX"><span class="uppercase">Now part of the LabX Media Group:</span><a class="uppercase" href="http://www.labmanager.com/" target="_blank">Lab Manager Magazine</a><span>|</span><a class="uppercase" href="https://www.labx.com/" target="_blank">LabX</a><span>|</span><a class="uppercase" href="http://www.labwrench.com/" target="_blank">LabWrench</a></div><div class="copyRight"><p class="uppercase">&copy; 1986 - 2019 <em>The Scientist</em>. All rights reserved.</p></div></div></footer></div><div id="Torpedo"><div id="CookiePolicyContainer"></div><div class="fader"></div><section class="advertisement" data-zone="TS_WEB_ROS_SCROLLING-FOOTER_NULL_1000X60" id="ts-web-ros-scrolling-footer-null-1000x60"></section></div><section class="advertisement" data-zone="TS_WEB_ROS_OUTOFPAGE" id="ts-web-ros-outofpage"></section><script src="https://cdn.the-scientist.com/static/4.51.0/js/the-scientist-website.js"></script><script type="text/javascript" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=ra-5511aca60d81658e" async></script><script>(function(d,s,i,r) {if (d.getElementById(i)){return;}var n=d.createElement(s),e=d.getElementsByTagName(s)[0];n.id=i;n.src='//js.hs-analytics.net/analytics/'+(Math.ceil(new Date()/r)*r)+'/547446.js';e.parentNode.insertBefore(n, e);})(document,"script","hs-analytics",300000);</script></body></html>